ChemicalBook
English   Japanese   Germany   Korea

5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole

, 680214-03-3, 结构式
CAS号:
680214-03-3
英文名:
5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole
英文别名:
2,6-Dichloro-4-[5-(1,2-oxazol-5-yl)-1,3,4-oxadiazol-2-yl]pyridine;Pyridine, 2,6-dichloro-4-[5-(5-isoxazolyl)-1,3,4-oxadiazol-2-yl]-;5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole
中文名:
中文别名:
CBNumber:
CB22696618
分子式:
C10H4Cl2N4O2
分子量:
283.07
MOL File:
680214-03-3.mol

5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole化学性质

沸点:
527.3±60.0 °C(Predicted)
密度:
1.552±0.06 g/cm3(Predicted)
酸度系数(pKa):
-4.96±0.50(Predicted)
安全信息
海关编码: 2934999090

5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole性质、用途与生产工艺

5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole 上下游产品信息

上游原料

下游产品


5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole 生产厂家

供应商联系电话电子邮件国家产品数优势度
A.J Chemicals sales@ajchem.in 印度 6124 58
SYNQUEST info@synquestlabs.com 美国 6881 62
APOLLO-NMR sales@apolloscientific.co.uk 英国 6097 88
MATRIX sales@matrixscientific.com 美国 6655 80
 

680214-03-3, 5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole 相关搜索:

  • 680214-03-3
  • Pyridine, 2,6-dichloro-4-[5-(5-isoxazolyl)-1,3,4-oxadiazol-2-yl]-
  • 5-[5-(2,6-Dichloropyridin-4-yl)-1,3,4-oxadiazol-2-yl]isoxazole, 2-(2,6-Dichloropyridin-4-yl)-5-(isoxazol-5-yl)-1,3,4-oxadiazole
  • 2,6-Dichloro-4-[5-(1,2-oxazol-5-yl)-1,3,4-oxadiazol-2-yl]pyridine
Copyright 2016 © ChemicalBook. All rights reserved